|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
and Regulates TGF-
induced EGF Receptor Activation and Cell Proliferation
Correspondence to: Rik Derynck, Department of Growth and Development, University of California at San Francisco, San Francisco, CA 94143-0640. Tel:(415) 476-7322 Fax:(415) 476-1499 E-mail:derynck{at}itsa.ucsf.edu.
Transforming growth factor-
(TGF-
) is a member of the EGF growth factor family. Both transmembrane TGF-
and the proteolytically released soluble TGF-
can bind to the EGF/TGF-
tyrosine kinase receptor (EGFR) and activate the EGFR-induced signaling pathways. We now demonstrate that transmembrane TGF-
physically interacts with CD9, a protein with four membrane spanning domains that is frequently coexpressed with TGF-
in carcinomas. This interaction was mediated through the extracellular domain of transmembrane TGF-
. CD9 expression strongly decreased the growth factor and PMA- induced proteolytic conversions of transmembrane to soluble TGF-
and strongly enhanced the TGF-
induced EGFR activation, presumably in conjunction with increased expression of transmembrane TGF-
. In juxtacrine assays, the CD9-induced EGFR hyperactivation by transmembrane TGF-
resulted in increased proliferation. In contrast, CD9 coexpression with transmembrane TGF-
decreased the autocrine growth stimulatory effect of TGF-
in epithelial cells. This decrease was associated with increased expression of the cdk inhibitor, p21CIP1. These data reveal that the association of CD9 with transmembrane TGF-
regulates ligand-induced activation of the EGFR, and results in altered cell proliferation.
Key Words:
transforming growth factor-
, CD9, epidermal growth factor receptor, ectodomain, shedding
This article has been cited by other articles:
|
|